Picato® gel receives EU marketing authorisation for treatment of actinic keratosis

Summary:

Today LEO Pharma announced that the European Commission (EC) has granted marketing authorisation for Picato® (ingenol mebutate) gel as a treatment for actinic keratosis in the European Union (EU).

Date: 19 November 2012, 13:11 PM EST
Source: LEO Pharma A/S
Related Sites: http://www.leo-pharma.com/
Show/Hide more...

Social Media Tools:


Click asset titles for downloads, embeds and more...

Photos

Today LEO Pharma announced that the European Commission (EC) has granted marketing authorisation for Picato® (ingenol mebutate) gel as a treatment for actinic keratosis in the European Union (EU).
Photo#1

Subscribe via RSS

RSSAll Content
RSSConsumer
RSSEntertainment
RSSFinancial
RSSGovernment
RSSHealthcare
RSSRetail
RSSTechnology

Register

Journalists who register may create email subscriptions to search results and a cart of assets to download. Click here to login, register or edit profile.

What Our Users
Are Saying

"I like the way the DC is easy to navigate, easy to find stories, easy to find when they were filed so you know if they’re out of date, and easy to see an on-line version of the available video" -- Allan C Lee, Director of News and Current Affairs